Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Staelens

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
Nuclear Medicine and Biology|September 3, 2015
Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimagingDavid Thomae, Stijn Servaes, Naiara Vazquez, et al.
EJNMMI Research|December 27, 2024
Biodistribution and dosimetry of the PET radioligand [<sup>18</sup>F]CHDI-650 in mice for detection of mutant huntingtin aggregatesJordy Akkermans, Alan Miranda, Jeroen Verhaeghe, et al.
Brain, Behavior, and Immunity|December 27, 2016
Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbiditiesDaniele Bertoglio, Jeroen Verhaeghe, Eva Santermans, et al.
Plos One|October 27, 2018
MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's diseaseDaniele Bertoglio, Jeroen Verhaeghe, Lauren Kosten, et al.
Psychiatry Research. Neuroimaging|January 25, 2016
Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunctionLauren Kosten, Jeroen Verhaeghe, Robert Verkerk, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.
Epilepsia|May 8, 2013
Ictal-onset localization through connectivity analysis of intracranial EEG signals in patients with refractory epilepsyPieter van Mierlo, Evelien Carrette, Hans Hallez, et al.
Nuclear Medicine and Biology|November 11, 2019
Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imagingEduardo Ruivo, Karuna Adhikari, Filipe Elvas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2019
<sup>18</sup>F-FDG PET, the early phases and the delivery rate of <sup>18</sup>F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against <sup>15</sup>O-H<sub>2</sub>O PETJulie Ottoy, Jeroen Verhaeghe, Ellis Niemantsverdriet, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 23, 2016
Evaluation of [<sup>18</sup> F]BR420 and [<sup>18</sup> F]BR351 as radiotracers for MMP-9 imaging in colorectal cancerNaiara Vazquez, Stephan Missault, Christel Vangestel, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Nuclear Medicine and Biology|September 3, 2015
Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimagingDavid Thomae, Stijn Servaes, Naiara Vazquez, et al.
EJNMMI Research|December 27, 2024
Biodistribution and dosimetry of the PET radioligand [<sup>18</sup>F]CHDI-650 in mice for detection of mutant huntingtin aggregatesJordy Akkermans, Alan Miranda, Jeroen Verhaeghe, et al.
Brain, Behavior, and Immunity|December 27, 2016
Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbiditiesDaniele Bertoglio, Jeroen Verhaeghe, Eva Santermans, et al.
Plos One|October 27, 2018
MR-based spatial normalization improves [18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's diseaseDaniele Bertoglio, Jeroen Verhaeghe, Lauren Kosten, et al.
Psychiatry Research. Neuroimaging|January 25, 2016
Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunctionLauren Kosten, Jeroen Verhaeghe, Robert Verkerk, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancerLiesbet Vervoort, Ingrid Burvenich, Steven Staelens, et al.
Epilepsia|May 8, 2013
Ictal-onset localization through connectivity analysis of intracranial EEG signals in patients with refractory epilepsyPieter van Mierlo, Evelien Carrette, Hans Hallez, et al.
Nuclear Medicine and Biology|November 11, 2019
Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imagingEduardo Ruivo, Karuna Adhikari, Filipe Elvas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 14, 2019
<sup>18</sup>F-FDG PET, the early phases and the delivery rate of <sup>18</sup>F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against <sup>15</sup>O-H<sub>2</sub>O PETJulie Ottoy, Jeroen Verhaeghe, Ellis Niemantsverdriet, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 23, 2016
Evaluation of [<sup>18</sup> F]BR420 and [<sup>18</sup> F]BR351 as radiotracers for MMP-9 imaging in colorectal cancerNaiara Vazquez, Stephan Missault, Christel Vangestel, et al.
Pageof 17